Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant (Pleural) Mesothelioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01655888
What this trial is testing

The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Azienda Ospedaliera Universitaria Senese 29
Testing effectiveness (Phase 2)Study completedNCT00024076
What this trial is testing

Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer

Who this might be right for
Lung CancerMalignant MesotheliomaMetastatic Cancer+1 more
Jonsson Comprehensive Cancer Center 30
Early research (Phase 1)Looking for participantsNCT05304208
What this trial is testing

DENdritic Cell Therapy Combined With SURgEry in Mesothelioma

Who this might be right for
Mesotheliomas Pleural
Erasmus Medical Center 16
Testing effectiveness (Phase 2)WithdrawnNCT01105390
What this trial is testing

AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT04775446
What this trial is testing

Evaluation of the Clinical/Biological Characteristics, Efficacy and Safety of Patients With Malignant Pleural Mesothelioma, Treated by Immunotherapy

Who this might be right for
Malignant Pleural Mesothelioma
Centre Hospitalier Intercommunal Creteil 116
Early research (Phase 1)UnknownNCT03852823
What this trial is testing

Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours

Who this might be right for
Advanced Solid TumoursCervical CancerMalignant Mesothelioma+2 more
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 192
Not applicableLooking for participantsNCT03683680
What this trial is testing

Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

Who this might be right for
Mesothelioma
Dana-Farber Cancer Institute 240
Early research (Phase 1)Ended earlyNCT03420963
What this trial is testing

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

Who this might be right for
Recurrent Cutaneous MelanomaRecurrent Lip and Oral Cavity CarcinomaRecurrent Malignant Endocrine Neoplasm+25 more
M.D. Anderson Cancer Center 12
Early research (Phase 1)Ended earlyNCT06299163
What this trial is testing

NM32-2668 in Adult Patients With Selected Advanced Solid Tumors

Who this might be right for
Ovarian CarcinomaFallopian Tube CarcinomaPeritoneal Carcinoma+10 more
Numab Therapeutics AG 11
Testing effectiveness (Phase 2)Study completedNCT03213301
What this trial is testing

Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.

Who this might be right for
Malignant Pleural Mesothelioma, Advanced
Swiss Cancer Institute 42
Testing effectiveness (Phase 2)Study completedNCT00006014
What this trial is testing

SU5416 in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
National Cancer Institute (NCI) 45
Early research (Phase 1)Study completedNCT06469138
What this trial is testing

Investigate 14C-bemcentinib in Healthy Male Subjects

Who this might be right for
Non-Small Cell Lung CancerMetastatic MelanomaAcute Myeloid Leukemia+5 more
BerGenBio ASA 6
Testing effectiveness (Phase 2)Ended earlyNCT01769547
What this trial is testing

A Phase II Study of Single-agent DOVitinib in Advanced Malignant PlEural Mesothelioma Which Has Progressed Following Prior Platinum-Antifolate Chemotherapy

Who this might be right for
Advanced Malignant Pleural MesotheliomaMPM
Ontario Clinical Oncology Group (OCOG) 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07131345
What this trial is testing

Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma

Who this might be right for
Malignant MesotheliomaMesothelioma
National Cancer Center, China 55
Early research (Phase 1)Study completedNCT05538572
What this trial is testing

PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors

Who this might be right for
Breast CancerGlioblastomaHead and Neck Squamous Cell Carcinoma+4 more
Prelude Therapeutics Incorporated 22
Testing effectiveness (Phase 2)Study completedNCT05795595
What this trial is testing

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaCervical CarcinomaEsophageal Carcinoma+2 more
CRISPR Therapeutics AG 19
Early research (Phase 1)Ended earlyNCT01143545
What this trial is testing

Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas

Who this might be right for
Lung CancerEsophageal CancerMalignant Pleural Mesothelioma+2 more
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Looking for participantsNCT06477419
What this trial is testing

Sacituzumab Govitecan in People With Mesothelioma

Who this might be right for
MesotheliomaMesotheliomas PleuralMesothelioma; Pleura
Memorial Sloan Kettering Cancer Center 33
Not applicableStudy completedNCT00867711
What this trial is testing

Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) Patients

Who this might be right for
MALIGNANT PLEURAL MESOTHELIOMA
Istituto Clinico Humanitas 121
Early research (Phase 1)Ended earlyNCT02838745
What this trial is testing

Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for MPM

Who this might be right for
Mesothelioma
Baylor College of Medicine 7
Next Page